Analysts Offer Insights on Healthcare Companies: Innoviva Inc (NASDAQ: INVA) and Endo International (NASDAQ: ENDP)

By Jason Carr

Analysts fell to the sidelines weighing in on Innoviva Inc (NASDAQ: INVA) and Endo International (NASDAQ: ENDP) with neutral ratings,indicating that the experts are neither bullish nor bearish on the stocks.

Innoviva Inc (NASDAQ: INVA)

In a report issued on September 15, Stephen Willey from Stifel Nicolaus reiterated a Hold rating on Innoviva Inc (NASDAQ: INVA), with a price target of $15. The company’s shares closed on Friday at $13.87, close to its 52-week high of $14.55.

According to TipRanks.com, Willey is a 5-star analyst with an average return of 22.4% and a 55.8% success rate. Willey covers the Healthcare sector, focusing on stocks such as Arbutus Biopharma Corporation, Applied Genetic Technologies, and Hutchison China MediTech Ltd.

Currently, the analyst consensus on Innoviva Inc is Moderate Buy and the average price target is $14.67, representing a 5.8% upside.

In a report issued on September 11, Robert W. Baird also reiterated a Hold rating on the stock with a $13 price target.
Endo International (NASDAQ: ENDP)

In a report issued on September 15, Annabel Samimy from Stifel Nicolaus reiterated a Hold rating on Endo International (NASDAQ: ENDP), with a price target of $15. The company’s shares closed on Friday at $8.60, close to its 52-week low of $7.41.

According to TipRanks.com, Samimy is a 4-star analyst with an average return of 10.6% and a 49.4% success rate. Samimy covers the Healthcare sector, focusing on stocks such as Strongbridge Biopharma Plc, Corcept Therapeutics Inc, and Supernus Pharmaceuticals.

Currently, the analyst consensus on Endo International is Hold and the average price target is $12.33, representing a 43.4% upside.

In a report issued on September 6, Canaccord Genuity also maintained a Hold rating on the stock with a $10 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.